161 related articles for article (PubMed ID: 38675462)
21. Analysis of bioactive components and synergistic action mechanism of ShuGan-QieZhi Capsule for treating non-alcoholic fatty liver disease.
Zhu T; Huang X; Zhu H; Chen J; Yao H; Zhang Y; Hua H; Zhang J; Qi J
Phytomedicine; 2024 Jan; 123():155173. PubMed ID: 37976695
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial Peroxiredoxin III Protects against Non-Alcoholic Fatty Liver Disease Caused by a Methionine-Choline Deficient Diet.
Park J; Kim NH; Yi HJ; Rhee SG; Woo HA
Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670871
[TBL] [Abstract][Full Text] [Related]
23. Low-Dose Administration of Cannabigerol Attenuates Inflammation and Fibrosis Associated with Methionine/Choline Deficient Diet-Induced NASH Model via Modulation of Cannabinoid Receptor.
Aljobaily N; Krutsinger K; Viereckl MJ; Joly R; Menlove B; Cone B; Suppes A; Han Y
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615835
[TBL] [Abstract][Full Text] [Related]
24. Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
Hu J; Zheng Y; Ying H; Ma H; Li L; Zhao Y
Nutrients; 2022 Sep; 14(18):. PubMed ID: 36145172
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota and bile acids partially mediate the improvement of fibroblast growth factor 21 on methionine-choline-deficient diet-induced non-alcoholic fatty liver disease mice.
Lin D; Sun Q; Liu Z; Pan J; Zhu J; Wang S; Jia S; Zheng M; Li X; Gong F
Free Radic Biol Med; 2023 Feb; 195():199-218. PubMed ID: 36586452
[TBL] [Abstract][Full Text] [Related]
26. iPla2β deficiency in mice fed with MCD diet does not correct the defect of phospholipid remodeling but attenuates hepatocellular injury via an inhibition of lipid uptake genes.
Zhu X; Gan-Schreier H; Otto AC; Cheng Y; Staffer S; Tuma-Kellner S; Ganzha A; Liebisch G; Chamulitrat W
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 May; 1864(5):677-687. PubMed ID: 30735854
[TBL] [Abstract][Full Text] [Related]
27. Wuzhi capsule (Schisandra Sphenanthera extract) attenuates liver steatosis and inflammation during non-alcoholic fatty liver disease development.
Chen Z; Liu F; Zheng N; Guo M; Bao L; Zhan Y; Zhang M; Zhao Y; Guo W; Ding G
Biomed Pharmacother; 2019 Feb; 110():285-293. PubMed ID: 30522014
[TBL] [Abstract][Full Text] [Related]
28. Metabolic impact of partial hepatectomy in the non-alcoholic steatohepatitis animal model of methionine-choline deficient diet.
Carril E; Valdecantos MP; Lanzón B; Angulo S; Valverde ÁM; Godzien J; Rupérez FJ
J Pharm Biomed Anal; 2020 Jan; 178():112958. PubMed ID: 31718984
[TBL] [Abstract][Full Text] [Related]
29. Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease.
Liu L; Zhao J; Zhang R; Wang X; Wang Y; Chen Y; Feng R
J Pharm Biomed Anal; 2021 Jun; 200():114058. PubMed ID: 33865049
[TBL] [Abstract][Full Text] [Related]
30. Visfatin exacerbates hepatic inflammation and fibrosis in a methionine-choline-deficient diet mouse model.
Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
J Gastroenterol Hepatol; 2021 Sep; 36(9):2592-2600. PubMed ID: 33600604
[TBL] [Abstract][Full Text] [Related]
31. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
[TBL] [Abstract][Full Text] [Related]
32. Protective Effect of
Biao Y; Chen J; Liu C; Wang R; Han X; Li L; Zhang Y
Front Pharmacol; 2022; 13():877924. PubMed ID: 35800450
[TBL] [Abstract][Full Text] [Related]
33. The Ameliorating Effects of n-3 Polyunsaturated Fatty Acids on Liver Steatosis Induced by a High-Fat Methionine Choline-Deficient Diet in Mice.
Šmíd V; Dvořák K; Stehnová K; Strnad H; Rubert J; Stříteský J; Staňková B; Stránská M; Hajšlová J; Brůha R; Vítek L
Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139055
[TBL] [Abstract][Full Text] [Related]
34.
Zhu M; Hao S; Liu T; Yang L; Zheng P; Zhang L; Ji G
Oncotarget; 2017 Oct; 8(47):82621-82631. PubMed ID: 29137289
[TBL] [Abstract][Full Text] [Related]
35. Hepatoprotective effect of Qushihuayu formula on non-alcoholic steatohepatitis induced by MCD diet in rat.
Lan Q; Ren Z; Chen Y; Cui G; Choi IC; Ung COL; Yu HH; Lee SM
Chin Med; 2021 Mar; 16(1):27. PubMed ID: 33726778
[TBL] [Abstract][Full Text] [Related]
36. (Pro)Renin Receptor Antagonism Attenuates High-Fat-Diet-Induced Hepatic Steatosis.
Gayban AJB; Souza LAC; Cooper SG; Regalado E; Kleemann R; Feng Earley Y
Biomolecules; 2023 Jan; 13(1):. PubMed ID: 36671527
[TBL] [Abstract][Full Text] [Related]
37. Clinical and Metabolic Characterization of Lean Caucasian Subjects With Non-alcoholic Fatty Liver.
Feldman A; Eder SK; Felder TK; Kedenko L; Paulweber B; Stadlmayr A; Huber-Schönauer U; Niederseer D; Stickel F; Auer S; Haschke-Becher E; Patsch W; Datz C; Aigner E
Am J Gastroenterol; 2017 Jan; 112(1):102-110. PubMed ID: 27527746
[TBL] [Abstract][Full Text] [Related]
38. Dietary oleate has beneficial effects on every step of non-alcoholic Fatty liver disease progression in a methionine- and choline-deficient diet-fed animal model.
Lee JY; Moon JH; Park JS; Lee BW; Kang ES; Ahn CW; Lee HC; Cha BS
Diabetes Metab J; 2011 Oct; 35(5):489-96. PubMed ID: 22111040
[TBL] [Abstract][Full Text] [Related]
39. An unbiased lipidomics approach identifies key lipid molecules as potential therapeutic targets of Dohongsamul-tang against non-alcoholic fatty liver diseases in a mouse model of obesity.
Park SH; Lee JE; Lee SM; Lee J; Seo CS; Hwang GS; Jung J
J Ethnopharmacol; 2020 Oct; 260():112999. PubMed ID: 32454173
[TBL] [Abstract][Full Text] [Related]
40. Hepatoprotective Effect of Jianpi Huoxue Formula on Nonalcoholic Fatty Liver Disease Induced by Methionine-Choline-Deficient Diet in Rat.
Feng Y; Chen Y; Yang B; Lan Q; Wang T; Cui G; Ren Z; Choi IC; Leung GP; Yan F; Chen D; Yu HH; Lee SMY
Biomed Res Int; 2019; 2019():7465272. PubMed ID: 31355279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
